Woojin Plaimm우진플라임

Woojin Plaimm is back near break-even on a trailing basis, with thin margins, heavy borrowings and a share price well below its 52-week high.

Woojin Plaimm, a Korean maker of plastic injection molding machines, reported trailing twelve-month revenue of ₩201B to H1 2026 but an operating loss of about ₩1.3B, with a small net profit of ₩2.5B. Borrowings of ₩139B are large against ₩15.6B of cash, and liabilities are about 2.2 times equity. The shares closed at ₩1,812, roughly half the 52-week high of ₩3,700.

What stands out

• Revenue has been roughly flat, from ₩212B in 2023 to ₩212B in 2025, after a steep drop in 2023 and a sharp fall in profit from 2022.
• Operating margin fell from 8.9% in 2022 to 1.4% in 2025 and is slightly negative on a trailing basis to H1 2026.
• Net income is above operating income on a trailing basis, which the data does not explain; the filings would need to be checked for the cause.
• Trailing free cash flow is negative at about -₩2.4B, and ROE is 2.3%.
• Recent filings are mostly routine shareholding reports and a corporate value-up plan dated 30 September 2026; a news item on 14 October 2026 described eco-friendly injection molding technology aimed at plastic regulations.

What to watch

• The full-year 2026 results and any change in the trailing operating loss.
• Progress on the corporate value-up plan and the detail in future filings.
• Debt levels and cash flow, given borrowings of ₩139B and negative free cash flow; the data does not include a dividend, so none is shown.